1szm
From Proteopedia
Line 1: | Line 1: | ||
- | [[Image:1szm.gif|left|200px]] | + | [[Image:1szm.gif|left|200px]] |
- | + | ||
- | '''DUAL BINDING MODE OF BISINDOLYLMALEIMIDE 2 TO PROTEIN KINASE A (PKA)''' | + | {{Structure |
+ | |PDB= 1szm |SIZE=350|CAPTION= <scene name='initialview01'>1szm</scene>, resolution 2.50Å | ||
+ | |SITE= | ||
+ | |LIGAND= <scene name='pdbligand=BI4:3-(1H-INDOL-3-YL)-4-{1-[2-(1-METHYLPYRROLIDIN-2-YL)ETHYL]-1H-INDOL-3-YL}-1H-PYRROLE-2,5-DIONE'>BI4</scene> | ||
+ | |ACTIVITY= [http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] | ||
+ | |GENE= PRKACA ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9913 Bos taurus]) | ||
+ | }} | ||
+ | |||
+ | '''DUAL BINDING MODE OF BISINDOLYLMALEIMIDE 2 TO PROTEIN KINASE A (PKA)''' | ||
+ | |||
==Overview== | ==Overview== | ||
Line 7: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
- | 1SZM is a [ | + | 1SZM is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1SZM OCA]. |
==Reference== | ==Reference== | ||
- | The protein kinase C inhibitor bisindolyl maleimide 2 binds with reversed orientations to different conformations of protein kinase A., Gassel M, Breitenlechner CB, Konig N, Huber R, Engh RA, Bossemeyer D, J Biol Chem. 2004 May 28;279(22):23679-90. Epub 2004 Mar 1. PMID:[http:// | + | The protein kinase C inhibitor bisindolyl maleimide 2 binds with reversed orientations to different conformations of protein kinase A., Gassel M, Breitenlechner CB, Konig N, Huber R, Engh RA, Bossemeyer D, J Biol Chem. 2004 May 28;279(22):23679-90. Epub 2004 Mar 1. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/14996846 14996846] |
[[Category: Bos taurus]] | [[Category: Bos taurus]] | ||
[[Category: Non-specific serine/threonine protein kinase]] | [[Category: Non-specific serine/threonine protein kinase]] | ||
Line 30: | Line 39: | ||
[[Category: x-ray structure]] | [[Category: x-ray structure]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 14:11:40 2008'' |
Revision as of 12:11, 20 March 2008
| |||||||
, resolution 2.50Å | |||||||
---|---|---|---|---|---|---|---|
Ligands: | |||||||
Gene: | PRKACA (Bos taurus) | ||||||
Activity: | Non-specific serine/threonine protein kinase, with EC number 2.7.11.1 | ||||||
Coordinates: | save as pdb, mmCIF, xml |
DUAL BINDING MODE OF BISINDOLYLMALEIMIDE 2 TO PROTEIN KINASE A (PKA)
Overview
As the key mediators of eukaryotic signal transduction, the protein kinases often cause disease, and in particular cancer, when disregulated. Appropriately selective protein kinase inhibitors are sought after as research tools and as therapeutic drugs; several have already proven valuable in clinical use. The AGC subfamily protein kinase C (PKC) was identified early as a cause of cancer, leading to the discovery of a variety of PKC inhibitors. Despite its importance and early discovery, no crystal structure for PKC has yet been reported. Therefore, we have co-crystallized PKC inhibitor bisindolyl maleimide 2 (BIM2) with PKA variants to study its binding interactions. BIM2 co-crystallized as an asymmetric pair of kinase-inhibitor complexes. In this asymmetric unit, the two kinase domains have different lobe configurations, and two different inhibitor conformers bind in different orientations. One kinase molecule (A) is partially open with respect to the catalytic conformation, the other (B) represents the most open conformation of PKA reported so far. In monomer A, the BIM2 inhibitor binds tightly via an induced fit in the ATP pocket. The indole moieties are rotated out of the plane with respect to the chemically related but planar inhibitor staurosporine. In molecule B a different conformer of BIM2 binds in a reversed orientation relative to the equivalent maleimide atoms in molecule A. Also, a critical active site salt bridge is disrupted, usually indicating the induction of an inactive conformation. Molecular modeling of the clinical phase III PKC inhibitor LY333531 into the electron density of BIM2 reveals the probable binding mechanism and explains selectivity properties of the inhibitor.
About this Structure
1SZM is a Single protein structure of sequence from Bos taurus. Full crystallographic information is available from OCA.
Reference
The protein kinase C inhibitor bisindolyl maleimide 2 binds with reversed orientations to different conformations of protein kinase A., Gassel M, Breitenlechner CB, Konig N, Huber R, Engh RA, Bossemeyer D, J Biol Chem. 2004 May 28;279(22):23679-90. Epub 2004 Mar 1. PMID:14996846
Page seeded by OCA on Thu Mar 20 14:11:40 2008
Categories: Bos taurus | Non-specific serine/threonine protein kinase | Single protein | Bossemeyer, D. | Breitenlechner, C B. | Engh, R A. | Gassel, M. | Huber, R. | Koenig, N. | BI4 | Amino acid residue exchange | Bisindolyl maleimide 2 | Ly333531 | Pka | Pkc | Selectivity | Surrogate kinase | X-ray structure